109 related articles for article (PubMed ID: 15280571)
1. Factors associated with abnormal Pap results in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Gordon C; Joseph L; Boivin JF; Rajan R; Allen A; Moore AD; Leung MH; Clarke A
Rheumatology (Oxford); 2004 Nov; 43(11):1386-9. PubMed ID: 15280571
[TBL] [Abstract][Full Text] [Related]
2. Reports of abnormal cervical cancer screening tests in systemic sclerosis.
Bernatsky S; Hudson M; Pope J; Markland J; Robinson D; Jones N; Docherty P; Abu-Hakima M; Leclerc S; Dunne J; Smith CD; Sutton E; Khalidi N; Mathieu JP; Masetto A; Ligier S; Kaminska E; Baron M;
Rheumatology (Oxford); 2009 Feb; 48(2):149-51. PubMed ID: 19074957
[TBL] [Abstract][Full Text] [Related]
3. [Squamous intraepithlelial lesions in women's lupus].
Mercado U
Ginecol Obstet Mex; 2009 Sep; 77(9):423-7. PubMed ID: 19899432
[TBL] [Abstract][Full Text] [Related]
4. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity.
Bernatsky S; Boivin JF; Joseph L; St Pierre Y; Moore A; Rajan R; Clarke A
J Rheumatol; 2002 Dec; 29(12):2551-4. PubMed ID: 12465150
[TBL] [Abstract][Full Text] [Related]
6. Hormonal exposures and breast cancer in a sample of women with systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R; Joseph L; Boivin JF; Rajan R; Moore AD; Leung MH; Allen A; Gordon C
Rheumatology (Oxford); 2004 Sep; 43(9):1178-81. PubMed ID: 15226516
[TBL] [Abstract][Full Text] [Related]
7. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
[TBL] [Abstract][Full Text] [Related]
8. Systemic lupus erythematosus: predisposition for uterine cervical dysplasia.
Blumenfeld Z; Lorber M; Yoffe N; Scharf Y
Lupus; 1994 Feb; 3(1):59-61. PubMed ID: 8025589
[TBL] [Abstract][Full Text] [Related]
9. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
[TBL] [Abstract][Full Text] [Related]
10. Risk of cervical abnormalities in women with inflammatory bowel disease: a population-based nested case-control study.
Singh H; Demers AA; Nugent Z; Mahmud SM; Kliewer EV; Bernstein CN
Gastroenterology; 2009 Feb; 136(2):451-8. PubMed ID: 18996382
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening in medically underserved California Latina and non-Latina women: effect of age and regularity of Pap testing.
Howell LP; Gurusinghe S; Tabnak F; Sciortino S
Cancer Detect Prev; 2009; 32(5-6):372-9. PubMed ID: 19264426
[TBL] [Abstract][Full Text] [Related]
12. Self-reported fractures and associated factors in women with systemic lupus erythematosus.
Lee C; Almagor O; Dunlop DD; Manzi S; Spies S; Ramsey-Goldman R
J Rheumatol; 2007 Oct; 34(10):2018-23. PubMed ID: 17787041
[TBL] [Abstract][Full Text] [Related]
13. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of women with cervical intraepithelial dysplasia.
Michielutte R; Diseker RA; Corbett WT; May WJ
Prog Clin Biol Res; 1983; 130():203-15. PubMed ID: 6622455
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus.
Rhew EY; Lee C; Eksarko P; Dyer AR; Tily H; Spies S; Pope RM; Ramsey-Goldman R
J Rheumatol; 2008 Feb; 35(2):230-6. PubMed ID: 18203323
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
18. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
McLaurin EY; Holliday SL; Williams P; Brey RL
Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
[TBL] [Abstract][Full Text] [Related]
19. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
20. Informational needs and the experiences of women with abnormal Papanicolaou smears.
Bertram CC; Magnussen L
J Am Acad Nurse Pract; 2008 Sep; 20(9):455-62. PubMed ID: 18786022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
